Safety of Cotrimoxazole in Pregnancy

Nathan Ford(World Health Organization), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Jennifer Jao(Icahn School of Medicine at Mount Sinai), Zara Shubber(World Bank Group), Lisa Frigati(Red Cross War Memorial Children's Hospital), Elaine J. Abrams(ICAP Global Health)
JAIDS Journal of Acquired Immune Deficiency Syndromes
May 22, 2014
10.1097/qai.0000000000000211
Cited by 37

Related Papers

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
|BMJ|2020|2.4k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697
Measles Antibody: Reevaluation of Protective Titers
|The Journal of Infectious Diseases|1990|612